Athanor Capital, LP Omeros Corp Transaction History

Athanor Capital, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$14.52 - $23.53 $248,219 - $402,245	-17,095 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$10.14 - $15.19 $435,056 - $651,726	-42,905 Reduced 71.51%	17,095 $244,000
Q3 2020 Nov 16, 2020	BUY	$9.57 - $21.32 $277,022 - $617,150	28,947 Added 93.22%	60,000 $606,000
Q2 2020 Aug 13, 2020	BUY	$12.21 - $16.99 $379,157 - $527,590	31,053 New	31,053 $457,000

124

25.7M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $557M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Athanor Capital, LP with notifications on news.